Health Care Professionals

Abound's safety and efficacy have been tested
in 7 clinical trials, including studies in:

  • Healthy adult volunteers1
  • Critically injured trauma patients2
  • Men in resistance training3
  • Cancer patients4,5,6
  • People with HIV/AIDS7
     
Studies have shown that Abound:
  • Enhances processes involved in wound healing1
  • Helps reduce loss of lean tissue and increase body mass4-7
  • Supports wound repair1
  • Supports immune function7

 

References:
1. Williams JZ, Abumrad N, Barbul A. Effect of a specialized amino acid mixture on human collagen deposition. Ann Surg. Sep 2002;236(3):369-374; discussion 374-365.
2. Kuhls DA, Rathmacher JA, Musngi MD, et al. Beta-hydroxy-beta-methylbutyrate supplementation in critically ill trauma patients. J Trauma. Jan 2007;62(1):125-131; discussion 131-122.
3. Panton L, Rathmacher J, Baier S, Nissen S. Nutritional supplementation of the leucine metabolite beta-hydroxy-beta-methylbutyrate (HMB) during resistance training. Nutrition. 2000;16:734-739.
4. May PE, Barber A, D'Olimpio JT, Hourihane A, Abumrad NN. Reversal of cancer-related wasting using oral supplementation with a combination of beta-hydroxy-beta-methylbutyrate, arginine, and glutamine. Am J Surg. Apr 2002;183(4):471-479.
5. Rathmacher JA, Nissen S, Panton L, et al. Supplementation with a combination of beta-hydroxy-beta-methylbutyrate (HMB), arginine, and glutamine is safe and could improve hematological parameters. J Parenter Enteral Nutr. Mar-Apr 2004;28(2):65-75.
6. Berk L, James J, Schwartz A, et al. A randomized, double-blind, placebo-controlled trial of a beta hydroxyl beta-methyl butyrate, glutamine, and arginine mixture for the treatment of cancer cachexia (RTOG 0122). Support Care Cancer. Feb 22 2008.
7. Clark RH, Feleke G, Din M, et al. Nutritional treatment for acquired immunodeficiency virus-associated wasting using beta-hydroxy beta-methylbutyrate, glutamine, and arginine: a randomized, double-blind, placebo-controlled study. J Parenter Enteral Nutr. May-Jun 2000;24(3):133-139.